Celltrion Confirms EU Bevacizumab Filing

CT-P16 Biosimilar Rival To Avastin Has Been Submitted To The EMA

 
• By David Wallace
  
EMA
Celltrion has filed CT-P16 with the EMA
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products